Animal models for Clinical Psychopharmacology: Depression, Anxiety, Schizophrenia

References

• Abramson L. Y., Seligman M. E. P. Modeling psychopathology in the laboratory: history and rationale. Psycho-pathology: Experimental Models, J. D. Maser, M. E. P. Seligman. Freeman, San Francisco, 1–26
   Google Scholar
• Abramso L. Y., Seligman M. E. P., Teasdale J. D. Learned helplessness in humans: critique and reformulation. Journal of Abnormal Psychology 1978; 8(7)49–74
   Google Scholar
• Abramson L. Y., Metalsky G., Alloy L. B. Hopelessness depression: a theory-based subtype of depression. Psychological Reviews 1989; 9(6)358–372
   Google Scholar
• American Psychiatric Association. DSM-IIIR: Diagnostic and Statistical Manual of Psychiatric disorders Revised),3rd edn. APA, Washington, DC 1987
   Google Scholar
• Andreasen N. C., Olsen S. A., Dennert J. W., Smith M. R. Ventricular enlargement in schizophrenia: relationship to positive and negative symptoms. American Journal of Psychiatry 1982; 13(9)297–302
   Google Scholar
• Angst J., Baastrup P., Grof P., Hippius H., Poldinger W., Weis P. The course of monopolar depression and bipolar psychoses. Psychiatrica Neurologica et Neurochirurgica 1973; 7(6)489–500
   Google Scholar
• Angst J., Dobler-Mikola A., Binder J. The Zurich Study: a prospective study of depressive, neurotic and psychosomatic syndromes—I. Problem, methodology. European Archives of Psychiatric and Neurological Sciences 1984; 234: 13–20
   PubMedGoogle Scholar
• Anisman H. A., Zacharko R. M. Depression: the predisposing influence of stress. Behavioral and Brain Sciences 1982; 5: 89–137
   Web of Science ®Google Scholar
• Asberg M., Eriksson B., Martensson B., Traskman-Bendz L., Wagner A. Therapeutic effects of serotonin uptake inhibitors in depression. Journal of Clinical Psychiatry 1986; 47((4)(Suppl))23–25
   PubMedGoogle Scholar
• Barnes T. R. E. Tardive dyskinesia: risk factors, pathophysiology and treatment. Recent Advances in Clinical Psychiatry, No. 6, K. Granville-Grossman. Churchill Livingstone, London 1988; 185–205
   Google Scholar
• Barrett J. E., Witkin J. M., Mansbach R. S., Skolnick P., Weissman B. A. Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone do not involve benzodiazepine receptor mechanism. Journal of Pharmacology and Experimental Therapeutics 1986; 23(8)1009–1013
   Google Scholar
• Baruch I., Hemsley D. R., Gray J. A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disorders 1988; 17(6)598–606
   Google Scholar
• Becker H. C., Jarvis M. F., Wagner G. C., Flaherty C. F. Medial and lateral amygdalectomy differentially influences consummatory negative contrast. Physiology and Behavior 1984; 3(3)707–712
   Google Scholar
• Berger B. D., Schuster R. An animal model of social interaction: implications for the analysis of drug action. Behavioral Models and the Analysis of Drug Action, M. Y. Spiegelstein, A. Levy. Elsevier, Amsterdam 1982; 415–428
   Google Scholar
• Bizot J. C., Thiebot M. H., Lebihan C., Soubrie P., Simon P. Effects of imipramine-like drugs and serotonin uptake blockers on delay of reward in rats: possible implication in the behavioral mechanism of action of antidepressants. Journal of Pharmacology and Experimental Therapeutics 1988a; 24(6)1144–1151
   Google Scholar
• Bizot J. C., Thiebot M. H., Puech A. J. Effects of 5-HT-related drugs on waiting capabilities in rats. Psychopharmacology 1988b; 96: S5
   Web of Science ®Google Scholar
• Blanchard R. J., Blanchard D. C., Young B. B., Rodgers R. J. Ethanol, diazepam and gepirone effects on reactions to distant predators and predatory loci. Society for Neuroscience Abstracts 1989; 15: 37
   Google Scholar
• Bleuler E. Dementia Praecox or the Group of Schizophrenia. Universities Press, New York 1950
   Google Scholar
• Blumstein L. K., Crawley J. N. Further characterization of a simple automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacology, Biochemistry and Behavior 1983; 1(8)37–40
   Google Scholar
• Bodnoff S. R., Suranyi-Codotte B., Aitken D. H., Quirion R., Meanev M. Y. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 1988; 9(5)298–302
   Google Scholar
• Borsini F., Meli A. Is the forced swimming test a suitable test for revealing antidepressant activity?. Psychopharmacology 1988; 94: 147–160
   PubMed Web of Science ®Google Scholar
• Bourin M., Poncelelt M., Chermat R., Simon P. The value of the reserpine test in psycopharmacology. Arzneimittel-Forschung: Drug Research 1983; 3(3)1173–1176
   Google Scholar
• Boyer W. F., Feighner J. P. Update on the selective serotonin reuptake inhibitors. Paper presented at conference on New Pharmacological Approaches to Depression and Anxiety, IBC Technical Services, London, 1989
   Google Scholar
• Braff D. L., Stone C, Callaway E., Geyer M., Click I., Ball L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978; 1(5)339–343
   Google Scholar
• Brewin C. R. Cognitive Foundations of Clinical Psychology. Erlbaum, London 1988
   Google Scholar
• Broekkamp C. L., Garrigou D., Lloyd K. G. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacology, Biochemistry and Behavior 1980; 1(3)643–646
   Google Scholar
• Brown G. W. A psychosocial view of depression. Community Psychiatry, D. H. Bennett, H. Freeman. Churchill Livingstone, London 1989, in press
   Google Scholar
• Brown G. W., Sklair F., Harris T. O., Birley J. L. T. Life events and psychiatric disorders. I. Some methodological issues. Psychological Medicine 1973; 3: 74–87
   PubMed Web of Science ®Google Scholar
• Cairncross K. D., Cox B., Forster C., Wren A. F. Olfactory projections systems, drugs and behaviour: A review. Psychoneuroendocrinology 1979; 4: 253–272
   PubMedGoogle Scholar
• Carey M. P., Fry J. P. An evaluation of light aversion as a measure of anxiolytic benzodiazepine activity in the mouse. European Journal of Neuroscience 1988, Suppl: 343
   Google Scholar
• Carpenter W. T., Heinrichs D. W., Wagman A. M. I. Deficit and non-deficit of schizophrenia. The concept. American Journal of Psychiatry 1988; 14(5)578–583
   Google Scholar
• Carroll B. J. The dexamethasone suppression test for melacholia. British Journal of Psychiatry 1982; 140: 292–304
   PubMed Web of Science ®Google Scholar
• Carroll B. J. Diagnostic validity and laboratory studies: rules of the game. The Validity of Psychiatric Diagnosis, L. N. Robins, J. E. Barett. Raven Press, New York 1989; 229–244
   Google Scholar
• Cassella J. V., Davis M. Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. Psychopharmacology 1985; 87: 278–282
   PubMed Web of Science ®Google Scholar
• Connell P. H. Amphetamine Psychosis, Maudsley Monographs No. 5. Oxford University Press, London 1958
   Google Scholar
• Cook L., Weidley E. Behavioral effects of some psychopharmacological agents. Annals of the New York Academy of Sciences 1957; 6(6)740–752
   Google Scholar
• Cookson J. Animal models of schizophrenia and mania: clinical perspectives. Behavioural Models in Psychopharmacology: theoretical, industrial and clinical perspectives, P. Willner. Cambridge University Press, Cambridge 1990, in press
   Google Scholar
• Cooper S. J. Benzodiazepines as appetite-enhancing compounds. Appetite 1980; 1: 7–19
   Web of Science ®Google Scholar
• Costall B. Anxiolytic potential of 5-HT3receptor antagonists. Paper presented at conference on New Pharmacological Approaches to Depression and Anxiety, IBC Technical Services, London, 1989
   Google Scholar
• Costall B., Domeney A. M., Naylor R. J., Tyers M. B. Effects of the 5-HT3receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rate and marmoset brain. British Journal of Pharmacology 1987; 92: 881–894
   PubMed Web of Science ®Google Scholar
• Costall B., Kelly M. E., Naylor R. J., Onaivi E. S. Actions of buspirone in a putative model of anxiety in the mouse. Journal of Pharmacy and Pharmacology 1988; 40: 494–500
   PubMed Web of Science ®Google Scholar
• Crawley J. N., Skolnick P., Paul S. M. Absence of intrinsic antagonistic actions of benzodiazepine antagonists on an exploratory model of anxiety in the mouse. Neuropharmacology 1984; 2(3)531–537
   Google Scholar
• Creese I. N. R., Burt D. R., Snyder S. H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 1976; 19(2)481–483
   Google Scholar
• Critchley M. A. E., Handley S. L. Effects in the X-maze anxiety model of agents acting at 5–HT1and 5–HT2receptors. Psychopharmacology 1987; 93: 502–506
   PubMed Web of Science ®Google Scholar
• Crow T. Two dimensions of pathology in schizophrenia: dopaminergic and non-dopaminergic. Psychopharmacology Bulletin 1980; 1(8)22–29
   Google Scholar
• Dall'olio R., Vaccheri A., Gandolfi O., Monta-Naro N. Behavioral differentiation between pharmacokinetic and pharmacodynamic components of the interaction of antidepressants or neuroleptics with methamphetamine. Psychopharmacology 1986; 90: 18–23
   PubMed Web of Science ®Google Scholar
• Davis M. Diazepam and flurazepam: effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology 1979; 6(2)1–7
   Google Scholar
• Davis M., Cassella J. V., Kehne J. H. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone. Psychopharmacology 1988; 9(4)14–20
   Google Scholar
• Delina-Stula A., Radeke E., Van Riezen H. Enhanced functional responsiveness of the dopaminergic system—The mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the rat. Neuropharmacology 1988; 9: 943–947
   Google Scholar
• Ellinwood E. H., Kilbey M. M. Chronic stimulant intoxication models of psychosis. Animal Models in Psychiatry and Neurology, T Hanin, E. Usdin. Pergamon Press, Oxford 1977; 61–74
   Google Scholar
• Ellinwood E. H., Kilbey M. M. Fundamental mechanisms underlying altered behavior following chronic administration of psychomotor stimulants. Biological Psychiatry 1980; 1(5)749–757
   Google Scholar
• Ellison G., Eison M. S. Continuous amphetamine intoxication: an animal model of the acute psychotic episode. Psychological Medicine 1983; 1(3)751–761
   Google Scholar
• Evenden J. L., Robbins T. W. Increased response switching, perseveration and perseverative switching following D-amphetamine in the art. Psycho-pharmacology 1983; 80: 67–73
   PubMed Web of Science ®Google Scholar
• Everttt B. J., Keverne E. B. Models of depression based on behavioural observations of experimental animals. Psychopharmacology of Affective Disorders, E. S. Paykel, A. Coppen. Oxford University Press, Oxford 1979; 41–59
   Google Scholar
• File S. E., Hyde J. R. G. Can social interaction be used to measure anxiety. British Journal of Pharmacology 1978; 6(2)19–24
   Google Scholar
• File S. E., Johnstone A. L. Lack of effects of 5-HT3receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat. Psycho-pharmacology 1989; 9(9)248–251
   Google Scholar
• File S. E., Wardill A. G. Validity of head-dipping as a measure of exploration in a modified holeboard. Psychopharmacologia 1975; 4(4)53–59
   Google Scholar
• Flaherty C. F., Grigson P. S., Rowan G. A. Chlordiazepoxide and the determinants of negative contrast. Animal Learning and Behavior 1986; 1(4)315–321
   Google Scholar
• Flaherty C. F., Grigson P. S., Demetrikopoulos P. S., Demetrikopoulos M. K. Effect of clonidine on consummatory negative contrast and on novelty-induced stress. Pharmacology, Biochemistry and Behavior 1987; 2(7)659–664
   Google Scholar
• Fontana D. J., Carbary T. J., Commisaris R. L. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psycho-pharmacology 1989; 9(8)157–162
   Google Scholar
• Fontana D. J., Schefke D. M., Commisaris R. L. Acute versus chronic clonidine treatment effects on conflict behavior in the rat. Behavioural Pharmacology 1990; 1: 201–208
   Google Scholar
• Frazer A., Lucki I., Sills M. Alterations in monoamine-containing neuronal function due to administration of antidepressants repeatedly to rats. Acta Pharmacologica et Toxicologica 1985; 56(Suppl. 1)21–34
   PubMedGoogle Scholar
• Frith C. D. The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychological Medicine 1987; 1(7)631–648
   Google Scholar
• Frith C. D., Done J. Stereotyped responding by schizophrenic patients on a two-choice guessing task. Psychological Medicine 1983; 1(3)779–786
   Google Scholar
• Fyer A. J., Mannuzza S., Endicott J. Differential diagnosis and assessment of anxiety: recent developments. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1177–1191
   Google Scholar
• Geller I., Seifter J. The effects of meprobamate, barbiturates, D-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1960; 9: 482–492
   Google Scholar
• Giral P., Martin P., Soubrie P., Simon P. Reversal of helpless behaviour in rats by putative 5-HT1Aagonists. Biological Psychiatry 1988; 2(3)237–242
   Google Scholar
• Glenn B., Green S. Anxiolytic profile of GR 38032F in the potentiated startle paradigm. Behavioural Pharmacology 1989; 1: 91–94
   PubMedGoogle Scholar
• Goldberg D., Simpson N. The diagnosis of anxiety in primary care settings. Drug Treatment of Neurotic Disorder, M. H. Lader, H. C. Davies. Churchill Livingstone, London 1985; 76–82
   Google Scholar
• Goosen C. Abnormal behavior patterns in rhesus monkeys: symptoms of mental disease?. Biological Psychiatry 1981; 16: 697–716
   PubMed Web of Science ®Google Scholar
• Gray J. A. The Neuropsychology of Anxiety: an enquiry into the functions of the septo-hippocampal system. Cambridge University Press, Cambridge 1982
   Google Scholar
• Green S., Hodges H. Animal models of anxiety. Behavioural Models in Psychopharmacology: theoretical, industrial and clinical perspectives, P. Willner. Cambridge University Press, Cambridge 1990, in press
   Google Scholar
• Griffiths J. D., Cavanaugh J., Held J., Gates J. Dextroamphetamine: evaluation of psychotomimetic properties in man. Archives of General Psychiatry 1972; 2(6)97–100
   Google Scholar
• Groenewegen H. J., Berendse H. W., Meredith G. E., Haber S. N., Voorn P., Wolters J. G., Lohman A. H. M. Functional anatomy of the ventral, limbic-system innervated striatum. The Mesolimbic Dopamine System: from motivation to action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990
   Google Scholar
• Guy A. P., Gardner C. R. Pharmacological characterization of a modified social interaction model of anxiety in the rat. Neuropsychobiology 1985; 1(3)194–200
   Google Scholar
• Henn F. A., McKinney W. T. Animal models in psychiatry. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 687–696
   Google Scholar
• Hillegaert V., Ahlenius S. Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol. Pharmacology and Toxicology 1987; 60: 350–354
   PubMedGoogle Scholar
• Hitchcock J., Davis M. Lesions of the amygdala, but not of the cerebellum or red nucleus, block conditioned fear as measured with the potentiated startle paradigm. Behavioral Neuroscience 1986; 100: 11–22
   PubMed Web of Science ®Google Scholar
• Hodges H., Baum S., Taylor P., Green S. Behavioural and pharmacological dissociation of chlordiazepoxide effects on discrimination and punished responding. Psychopharmacology 1986; 5(9)155–161
   Google Scholar
• Hodges H., Green S., Glenn B. Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology 1987; 9(2)491–504
   Google Scholar
• Hollister L. E. Drug-induced psychoses and schizophrenic reactions: a critical comparison. Annals of the New York Academy of Sciences 1962; 9(6)80–88
   Google Scholar
• Insel T. R., Zohar J. Psychopharmacologic approaches to obsessive-compulsive disorder. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1205–1210
   Google Scholar
• Iversen S. D. It is possible to model psychotic states in animals. Journal of Psychopharmacology 1987; 1: 154–176
   PubMedGoogle Scholar
• Jacobs B. L., Trulson M. E., Stern W. C. Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs. Brian Research 1977; 13(2)301–314
   Google Scholar
• Jesberger J. A., Richardson J. S. Animal models of depression: parallels and correlates to severe depression in humans. Biological Psychiatry 1985; 20: 764–784
   PubMed Web of Science ®Google Scholar
• Jesberger J. A., Richardson J. S. Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats. Behavioural Neuroscience 1986; 100: 256–274
   PubMed Web of Science ®Google Scholar
• Joly D., Sanger D. J. The effects of fluoxetine and zimelidine on the behavior of olfactory bulbectomized rats. Pharmacology, Biochemistry and Behavior 1986; 2(4)199–204
   Google Scholar
• Jones B. J., Costall B., Domeney A. M., Kelly M. E., Naylor R. J., Oakley N. R., Tyers M. B. The potential anxiolytic activity of GR 38032F, a 5-HT3receptor antagonist. British Journal of Pharmacology 1988; 93: 985–993
   PubMed Web of Science ®Google Scholar
• Jones G. H., Hernandez T. D., Marsden C. A., Robbins T. W. Enhanced striatal response to D-amphetamine as revealed by intracerebral dialysis following social isolation in rats. British Journal of Pharmacology 1988; 94: 349
   Web of Science ®Google Scholar
• Kahn R. J., McNair D. M., Lipman R. S., Covi L., Rickels K., Downing R., Fisher S., Franken-Thaler L. M. Imipramine and chlordiazepoxide in depressive and anxiety disorders, 2, Efficacy in anxious patients. Archives of General Psychiatry 1986; 43: 79–85
   PubMed Web of Science ®Google Scholar
• Kahn R. J., McNair D. M., Frankenthaler L. M. Tricyclic treatment of generalized anxiety disorder. Journal of Affective Disorders 1987; 1(3)145–151
   Google Scholar
• Katz R. J. Animal models and human depressive disorders. Neuroscience and Biobehavioral Reviews 1981; 5: 231–246
   PubMed Web of Science ®Google Scholar
• Kawashima K., Araki H., Aihara H. Effects of chronic administration of antidepressants on duration of immobility in rats forced to swim. Japanese Journal of Pharmacology 1986; 40: 199–204
   PubMedGoogle Scholar
• Keehn J. D. Psychopathology in Animals: research and clinical implications. Academic Press, New York 1979
   Google Scholar
• Klein D. F. Endogenomorphic depression: a conceptual and terminological revision. Archives of General Psychiatry 1974; 3(1)447–454
   Google Scholar
• Kline J., Reid K. H. The acute periventricular injury syndrome: a possible animal model for psychotic disease. Psychopharmacology 1985; 8(7)292–297
   Google Scholar
• Kokkinidis L., Zacharko R. M., Predy P. A. Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants. Pharmacology, Biochemistry and Behavior 1980; 1(3)379–383
   Google Scholar
• Kovelman J. A., Scheibel A. B. A neurohisto-logical correlate of schizophrenia. Biological Psychiatry 1984; 1(9)1601–1621
   Google Scholar
• Kraepelin E. Dementia Praecox and Paraphrenia. Livingstone, Edinburgh 1913
   Google Scholar
• Krsiak M., Sulcova A., Donat P., Tomasikova Z., Dlohozkova N., Kosar E., Masek K. Can social and agonistic interactions be used to detect anxiolytic activity of drugs. Ethopharmacological Aggression Research, K. A. Miczek, M. R. Kruk, B. Olivier. Liss, New York 1984; 93–114
   Google Scholar
• Kumar R. Animal models for screening new agents: a behavioural view. British Journal of Clinical Pharmacology 1976, Suppl: 13–17
   PubMedGoogle Scholar
• Kupfer D. J., Thase M. E. The use of the sleep laboratory in the diagnosis of affective disorders. Psychiatric Clinics of North America 1983; 6: 3–25
   PubMed Web of Science ®Google Scholar
• Lader M. Drug treatment of anxiety: implications for animal models. Behavioural Pharmacology 1989; 1: 95–100
   PubMedGoogle Scholar
• Lal H., Emmett-Oglesby M. W. Behavioral analogues of anxiety. Neuropharmacology 1983; 2(2)1423–1441
   Google Scholar
• Lehr E. Distress-call reactivation in isolated chicks: a behavioural indicator with high selectivity for antidepressants. Psychopharmacology 1989; 9(7)145–146
   Google Scholar
• Lewinsohn P. M. A behavioral approach to depression. The Psychology of Depression: contemporary theory and research, R. J. Friedman, M. M. Katz. Winston/Wiley, New York 1974; 157–185
   Google Scholar
• Lewinsohn P. M., Zeiss A. M., Zeiss R. A., Haller R. Endogenicity and reactivity as orthogonal dimensions in depression. Journal of Nervous and Mental Disorders 1977; 16(4)327–332
   Google Scholar
• Liddle P. F. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine 1987; 17: 49–57
   PubMed Web of Science ®Google Scholar
• Lloyd K. G., Garrigou D., Broekkamp C. L. E. The action of monoaminergic, cholinergic and GABAergic compounds in the olfactory bulbectomized rat model of depression. New Vistas in Depression, S. Z. Langer, R. Taka-Hashi, T. Segawa, M. Briley. Pergamon Press, New York 1982; 179–186
   Google Scholar
• Losonczy M. F., Davidson M., Davis K. L. The dopamine hypothesis of schizophrenia. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 715–726
   Google Scholar
• Lyon M. Animal models of mania and schizophrenia. Behavioural Models in Psychopharmacology: theoretical, industrial and clinical perspectives, P. Willner. Cambridge University Press, Cambridge 1990, in press
   Google Scholar
• Lyon M., Robbins T. W. The action of central nervous stimulant drugs: a general theory concerning amphetamine effects. Current Developments in Psychopharmacology, W Essman, L. Valzelli. Spectrum, New York 1975; Vol. 2: 79–163
   Google Scholar
• Lyon N., Mejsholm B., Lyon M. Stereotyped responding in schizophrenic outpatients: cross-cultural confirmation of perseverative switching on a two-choice task. Journal of Psychiatric Research 1986; 20: 137–150
   PubMed Web of Science ®Google Scholar
• Malick J. B., Enna S. S. Comparative effects of benzodiazepines and non-benzodiazepine anxiolytics on biochemical and behavioural tests predictive of anxiolytic activity. Communications in Psychopharmacology 1979; 3: 245–252
   PubMedGoogle Scholar
• Marek G. J., Li A., Seiden L. S. Selective 5-hydroxytryptamine-2 antagonists have antidepressant-like effects on differential-reinforcement-of-low-rate 72-s schedule. Journal of Pharmacology and Experimental Therapeutics 1989, in press
   Web of Science ®Google Scholar
• Martin P., Laporte A. M., Soubrie P., El Mesti-Kawy S., Hamon S. Reversal of helpless behaviour by serotonin reuptake inhibitors. Behavioural Pharmacology of 5-HT, P Sevan, A. R. Cools, T. Archer. Erlbaum, New York 1989; 231–234
   Google Scholar
• McKinney W. T., Bunney W. E. Animal model of depression: review of evidence and implications for research. Archives of General Psychiatry 1969; 2(1)240–248
   Google Scholar
• McKinney W. T., Moran E. C. Animal models of schizophrenia. American Journal of Psychiatry 1981; 13(8)478–483
   Google Scholar
• Meert T. F., Janssen P. A. J. The pharmacology of ritanserin: comparison with chlordiazepoxide. Drug Development Research 1989, in press
   Web of Science ®Google Scholar
• Miczek K. A. The psychopharmacology of aggression. Handbook of Psychopharmacology, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1987; Vol. 19: 183–328
   Google Scholar
• Mineka S., Cook M. Immunization against the observational conditioning of snake fear in monkeys. Journal of Abnormal Psychology 1986; 9(5)307–318
   Google Scholar
• Mineka S., Davidson M., Cook M., Kier R. Observational conditioning of snake fear in rhesus monkeys. Journal of Abnormal Psychology 1984; 9(3)355–372
   Google Scholar
• Minor T. R., Jackson R. L., Maier S. F. Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: evidence for a deficit in selective attention. Journal of Experimental Psychology: Animal Behavior Processes 1984; 10: 543–556
   PubMed Web of Science ®Google Scholar
• Minor T. R., Pelleymounter M. A., Maier S. F. Uncontrollable shock, forebrain norepinephrine, and stimulus selection during choice-escape learning. Psychobiology 1988; 16: 135–145
   Google Scholar
• Montgomery S. Are there new indications for antidepressive drugs? 5-HT reuptake inhibitors in the treatment of depression. Paper presented at conference on New Pharmacological Approaches to Depression and Anxiety, IBC Technical Service, London, 1989
   Google Scholar
• Muscat R., Sampson D., Willner P. Dopaminergic mechanism of imipramine action in an animal model of depression. Biological Psychiatry 1990; 2(8)223–229
   Google Scholar
• Nelson J. C. The use of antipsychotic drugs in the treatment of depression. Treating Resistant Depression, J Zohar, R. H. Belmaker. PMA, New York 1987; 131–146
   Google Scholar
• Nelson J. C., Charney D. S. The symptoms of major depression. American Journal of Psychiatry 1981; 13(8)1–13
   Google Scholar
• Nielsen E. B., Lyon M. Behavioral alterations during prolonged low level continuous amphetamine administration in a monkey family group (Cercopithecus aethiops). Biological Psychiatry 1982; 1(7)423–434
   Google Scholar
• Nielsen E. B., Lyon M., Ellison G. Apparent hallucinations in monkeys during round-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. Journal of Nervous and Mental Disease 1983; 17(1)222–233
   Google Scholar
• Oades R. D. Search strategies on a hole-board are impaired in rats with ventral tegmental damage: animal model for tests of thought disorder. Biological Psychiatry 1982; 1(7)243–258
   Google Scholar
• Oades R. D., Isaacson R. L. The development of food search behavior by rats: the effects of hippocampal damage and haloperidol treatment. Behavioral Biology 1978; 2(4)327–337
   Google Scholar
• Paykel E. S. Recent life events in the development of the depressive disorders. The Psychobiology of the Depressive Disorders: implications for the effects of stress, R. A. Depue. Academic Press, New York 1979; 245–262
   Google Scholar
• Paykel E. S., Rowan R. R., Rao B. M., Bhat A. Atypical antidepressants: nosology and response to antidepressants. Treatment of Depression: old controversies and new approaches, P. J. Clayton, J. E. Barrett. Raven Press, New York 1983; 247–252
   Google Scholar
• Pellow S. Anxiolytic and anxiogenic drug effects in a novel test of anxiety: are exploratory models of anxiety in rodents valid?. Methods and Findings in Experimental Clinical Pharmacology 1986; 8: 557–565
   PubMedGoogle Scholar
• Pellow S., Chopin P., File S. E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods 1985; 14: 149–167
   PubMed Web of Science ®Google Scholar
• Pellow S., Johnstone A. L., File S. E. Selective agonists and antagonists for 5-hydroxytrypt-amine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. Journal of Pharmacy and Pharmacology 1987; 39: 917–928
   PubMed Web of Science ®Google Scholar
• Petersen E. N., Scheel-Kruger J. The GABAergic anticonflict effects of intra–amygdaloid benzodiazepines demonstrated by a new waterlick conflict paradigm. Behavioral Models and the Analysis of Drug Action, M. Y. Spiegelstein, A. Levy. Elsevier, Amsterdam 1982; 467–473
   Google Scholar
• Pollard G. T., Howard J. L. Similar effects of antidepressant and non-antidepressant drugs on behavior under an interresponse time 72-s schedule. Psychopharmacology 1986; 89: 253–258
   PubMed Web of Science ®Google Scholar
• Porsolt R. D. Behavioural despair. Antidepressants: neurochemical, behavioral and clinical perspectives, S. J. Enna, J. B. Malick, E. Richelson. Raven Press, New York 1981; 121–139
   Google Scholar
• Porsolt R. D., LePichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatment. Nature 1977; 26(6)731–732
   Google Scholar
• Poschel B. P. H. A simple and specific screen for benzodizepine-like drugs. Psychopharmacologia 1971; 1(9)193–198
   Google Scholar
• Post R. M., Weiss S. R. B., Pert A. Animal models of mania. The Mesolimbic Dopamine System: from motivation to action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990
   Google Scholar
• Randrup A., Munkvad I. Behavioural toxicity of amphetamines: studies in animal experiments. The Correlation of Adverse Effects in Man with Observations in Animals, S. B. De, Baker. Excerpta Medica, Amsterdam 1971; 6–17
   Google Scholar
• Rickels K. Benzodiazepines in emotional disorders. The Benzodiazepines: current standards for medical practice, D. E. Smith, D. R. Wesson. MTP Press, Lancaster 1985; 97–109
   Google Scholar
• Rickels K., Schweizer E. E. Current pharmacotherapy of anxiety and panic. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1193–1203
   Google Scholar
• Ridley R. M., Baker H. F. Is there a relationship between social isolation, cognitive flexibility, and behavioural stereotypy? An analysis of the effects of amphetamine in marmosets. Ethology: primate models of neuropsychiatric disorders, K. A. Miczek. Liss, New York 1983; 101–135
   Google Scholar
• Ridley R. M., Baker H. F., Scragg P. R. The time course of the behavioural effects of amphetamine and their reversal by haloperidol in a primate species. Biological Psychiatry 1979; 1(4)753–765
   Google Scholar
• Rifkin A., Siris S. Drug treatment of acute schizophrenia. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1095–1101
   Google Scholar
• Robbins T. W. Cognitive deficits in schizophrenia and Parkinson's disease: neural basis and the role of dopamine. The Mesolimbic Dopamine System: from motivation to Action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990
   Google Scholar
• Robbins T. W., Sahakian B. J. Animal models of mania. Mania: an evolving concept, R Belmaker, H. Van Praag. Spectrum, New York 1980; 143–216
   Google Scholar
• Robichaud R. C., Sledge K. L. The effects of p-chlorophenylalanine on experimentally induced conflict in the rat. Life Science 1969; 8: 965–969
   PubMed Web of Science ®Google Scholar
• Robertson J., Bowlby J. Responses of young children to separation from their mothers. Cour du Centre Internationale de L'Enfance 1956; 2: 131–142
   Google Scholar
• Robinson D. S., Nies A., Ravaris C. K., Ives J. O., Bartlett D. Clinical pharmacology of phenelzine. Archives of General Psychiatry 1978; 3(5)629–635
   Google Scholar
• Sampson D., Willner P., Muscat R. Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 1977, in press
   Google Scholar
• Schmajuk N. A. Animal models of schizophrenia: the hippocampally lesioned animal. Schizophrenia Bulletin 1987; 1(3)317–327
   Google Scholar
• Schmale A. H. Adaptive role of depression in health and disease. Separation and Depression, J. P. Scott, E. Senay. American Association for the Advancement of Science, Washington, DC 1973; 187–214
   Google Scholar
• Seiden L. S. (1988) DRL-72 as a possible drug screen for antidepressants. Paper presented to European Behavioural Pharmacology Society, Athens, London, September, 1988
   Google Scholar
• Seiden L.S., Dahms J. L., Shoughnessy R. A. Behavioral screen for antidepressants: the effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 1985; 8(6)55–60
   Google Scholar
• Seligman M. E. P. Phobias and preparedness. Behavior Therapy 1971; 2: 307–320
   Web of Science ®Google Scholar
• Seligman M. E. P. Helplessness: on depression, development and death. Freeman, San Francisco 1975
   Google Scholar
• Sepinwall J., Cook L. Behavioural pharmacology of anti-axiety drugs. Handbook of Psycho-pharmacology, L. L. Iversen, S. D. Iversen, S. H. Snyder. Plenum Press, New York 1978; Vol. 13: 345–393
   Google Scholar
• Shader R. I., Greenblatt D. J. Some current treatment options for symptoms of anxiety. Journal of Clinical Psychiatry 1983; 44(11, Sec. 2)21–29
   PubMed Web of Science ®Google Scholar
• Shanks N., Anisman H. Stressor-provoked behavioral changes in six strains of mice. Behavioral Neuroscience 1988; 10(2)894–905
   Google Scholar
• Sheehan D. V. Triazalobenzodiazepines in the treatment of panic disorder and depressive symptoms: a critical review. Paper presented at conference on New Pharmacological Approaches to Depression and Anxiety, IBC Technical Services, London, 1989
   Google Scholar
• Shepherd J. K., Rodgers R. J. Acute and chronic effects of the triazolobenzodiazepine, alprazolam, on defeat and analgesia evoked by conspecific attack in male mice. Behavioural Pharmacology 1989; 1: 75–83
   PubMedGoogle Scholar
• Sherman A. D., Saquitne J. L., Petty F. Specificity of the learned helplessnesses model of depression. Pharmacology, Biochemistry and Behavior 1982; 16(6)449–454
   PubMedGoogle Scholar
• Simiand J., Keane P. E., Morre M. The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology 1984; 8(4)48–53
   Google Scholar
• Solomon P., Staton D. Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate nucleus on the rat's ability to ignore an irrelevant stimulus. Biological Psychiatry 1982; 1(7)743–756
   Google Scholar
• Soubrie P. Reconciling the role of central serotonin neurons in human and animal behaviour. Behavioral and Brain Sciences 1986; 9: 319–364
   Web of Science ®Google Scholar
• Spencer D. G., Schuurman T., Glaser T., Kummel B., Schollnhammer G., Trager J. Buspirone, ipsapirone and related compounds: 5-HT1Areceptors in anxiety. Paper presented at conference on New Pharmacological Approaches to Depression and Anxiety, IBC Technical Services, London, 1989
   Google Scholar
• Stephens D. N., Andrews J. S. Screening for anxiolytic drugs. Behavioural Models in Psychopharmacology: theoretical, industrial and clinical perspectives, P. Willner. Cambridge University Press, Cambridge 1990
   Google Scholar
• Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985; 8(5)367–370
   Google Scholar
• Stille G., Sayers A. Die Immobilisationsreaktion der Ratte als tierexperimentelles Modell for die Katatonie. Pharmackopsychiatrie 1975; 8: 105–114
   PubMedGoogle Scholar
• Suomi S. J. Factor affecting responses to social separation in rhesus monkeys. Animal Models in Human Psychobiology, G Serban, A. Kling. Plenum Press, New York 1976; 9–26
   Google Scholar
• Swerdlow N. R., Braff D. L., Geyer M. A., Koob G. F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biological Psychiatry 1986; 2(1)23–33
   Google Scholar
• Tamminga C. A., Gerlach J. New neuroleptics and experimental antipsychotics in schizophrenia. Psychopharmacology: the third generation of progress, H. Y. Meltzer. Raven Press, New York 1987; 1129–1140
   Google Scholar
• Tassin J.-P., Herve D., Vezina P., Trovero F., Blanc G., Glowinski J. Relationships between mesocortical and mesolimbic dopamine neurons: functional consequences of Dl receptors hetero-regulation. The Mesolimbic Dopamine System: from motivation to action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990
   Google Scholar
• Treit D. Animal models for the study of anti-anxiety agents: a review. Neuroscience and Biobehavioral Reviews 1985; 9: 203–222
   PubMed Web of Science ®Google Scholar
• Tyrer P. Clinical use of monoamine oxidase inhibitors. Psychopharmacology of Affective Disorders, E. S. Paykel, A. Coppen. Oxford University Press, Oxford 1979; 159–178
   Google Scholar
• Tyrer P., Candy J., Kelly D. A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacologia 1973; 3(2)237–254
   Google Scholar
• Tyrer P., Murphy S., Owen R. T. The risk of pharmacological dependence with buspirone. British Journal of Clinical Practice 1985; 39(Suppl. 38)91–93
   PubMedGoogle Scholar
• Uhde T. W., Stein M. B., Vittone B. J., Siever L. J., Boulenger J.-P., Klein E., Mellman T. A. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder. Archives of General Psychiatry 1989; 4(6)170–177
   Google Scholar
• Van Boer J. A., Westenberg H. G. M. Effect of a serotonin and noradrenaline uptake inhibitor in panic disorders: a double-blind comparative study with fluvoxamine and maprotiline. International Clinical Psychopharmacology, 3: 59–74
   Web of Science ®Google Scholar
• Van Riezen H., Leonard B. E. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbecomized tats. Journal of Pharmacology and Experimental Therapeutics 1990, in press
   Google Scholar
• Vernon R. E. Personality Assessment: a critical survey. Methuen, London 1963
   Google Scholar
• Vogel J. R., Beer B., Clody D. E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 1971; 2(1)1–7
   Google Scholar
• Weiner H. Some thoughts on behavioral approaches to therapy. Psychological Record 1973; 2(3)441–450
   Google Scholar
• Weiner I., Lubow R. E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 1984; 9(1)248–253
   Google Scholar
• Weiss J. M., Bailey W. H., Goodman P. A., Hoffman L. J., Ambrose M. J., Salman S., Gharry J. M. A model for the neurochemical study of depression. Behavioral Models and the Analysis of Drug Action, M. Y. Spiegelstein, A. Levy. Elsevier, Amsterdam 1982; 195–223
   Google Scholar
• Weissman B. A., Barrett J. E., Brady L. S., Witkin J. M., Mendelson W. B., Paul S. M., Skolnick P. Behavioral and neurochemical studies on the anticonflict actions of buspirone. Drug Development Research 1984; 4: 83–93
   Web of Science ®Google Scholar
• White F. J., Wang R. Y. Differential effects of classical and atypical neuroleptic drugs on A9 and A10 dopamine neurons. Science 1983; 22(1)1054–1057
   Google Scholar
• Willner P. The validity of animal models of depression. Psychopharmacology 1984; 8(3)1–16
   Google Scholar
• Willner P. Depression: a psychobiological synthesis. Wiley, New York 1985
   Google Scholar
• Willner P. Validating criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Progress in Neuropsychopharmacology and Biological Psychiatry 1986; 10: 677–690
   PubMed Web of Science ®Google Scholar
• Willner P. Sensitization to the actions of antidepressant drugs. Psychoactive Drugs: tolerance and sensitization, M. W. Emmett-Oglesby, A. J. Goudie. Humana Press, Cliffon, NJ 1989a; 407–459
   Google Scholar
• Willner P. Towards a theory of serotonergic dysfunction in depression. Behavioural Pharmacology of 5-HT, P Bevan, A. R. Cools, T. Archer. Erlbaum, New York 1989b; 157–178
   Google Scholar
• Willner P. Behavioural models in psychopharmacology. Behavioural Models in Psychopharmacology: theoretical, industrial and clinical perspectives, P. Willner. Cambridge University Press, Cambridge 1990a, in press
   Google Scholar
• Willner P. Animal models of depression: an overview. Pharmacology and Therapeutics 1990b; 4(5)425–455
   Google Scholar
• Willner P., Towell A., Sampson D., Muscat R., Sophokleous S. Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 1987; 9(3)358–364
   Google Scholar
• Willner P., Sampson D., Phillips G., Fichera R., Foxlow P., Muscat R. Effects of isolated housing and chronic antidepressant treatment on cooperative social behaviour in rats. Behavioural Pharmacology 1989; 1: 85–90
   PubMedGoogle Scholar
• Willner P., Muscat R., Papp M., Sampson D. Dopamine, depression and antidepressant drugs. The Mesolimbic Dopamine System: from motivation to action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990, in press
   Google Scholar
• Zacharko R. M., Anisman H. Stressor-provoked alterations in intracranial self-stimulation in the mesocorticolimbic system: an animal model of depression. The Mesolimbic Dopamine System: from motivation to action, P Willner, J. Scheel-Kruger. Wiley, Chichester 1990, in press
   Google Scholar
• Zacharko R. M., Bowers W. J., Kokkinidis L., Anisman H. Region-specific reductions of intracranial self-stimulation after uncontrollable stress: possible effects on reward processes. Behavioral Brain Research 1983; 9: 129–141
   PubMed Web of Science ®Google Scholar
• Zacharko R. M, Lalonde G. T., Kasian M., Anisman H. Strain specific effects of inescapable shock on intracranial self-stimulation from the nucleus accumbens. Brian Research 1987; 42(6)164–168
   Google Scholar
• Zis A. P., Goodwin F. K. Novel antidepressants and the biogenic amine hypothesis of depression. The case of iprindole and mianserin. Archives of General Psychiatry 1979; 3(6)1097–1107
   Google Scholar